195 related articles for article (PubMed ID: 36512064)
1. SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques.
Vabanesi M; Pinto AL; Vogrig A; Goncalves D; Rogemond V; Joubert B; Fabien N; Honnorat J; Muñiz-Castrillo S
J Neurol; 2023 Mar; 270(3):1691-1701. PubMed ID: 36512064
[TBL] [Abstract][Full Text] [Related]
2. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
3. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
4. Anti-SOX1 Antibody-Positive Paraneoplastic Syndrome Presenting with Subacute Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome: A Case Report.
Cheng YC; Chang A; Hsu WC
Acta Neurol Taiwan; 2021 Jun; 30(2)():74-77. PubMed ID: 34549392
[TBL] [Abstract][Full Text] [Related]
5. Expanding the spectrum of SOX1-antibodies in neuropathy: the coexistence of anti-SOX1 and Guillain-Barré syndrome-a case report.
Coniglio S; Turchi G; Giovannini G; Mazzoli M; Meletti S; Vaudano AE
Neurol Sci; 2022 Jun; 43(6):3979-3982. PubMed ID: 35391602
[TBL] [Abstract][Full Text] [Related]
6. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
7. Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies.
Arnaldos-Pérez C; Vilaseca A; Naranjo L; Sabater L; Dalmau J; Ruiz-García R; Graus F
Front Immunol; 2023; 14():1173484. PubMed ID: 37207233
[TBL] [Abstract][Full Text] [Related]
8. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
9. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
10. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
Front Immunol; 2019; 10():769. PubMed ID: 31031763
[TBL] [Abstract][Full Text] [Related]
11. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
12. Discordant SOX-1 antibodies results in paraneoplastic Lambert-Eaton syndrome diagnosis by the clinical laboratory.
Pozo-Giraldez A; Rodríguez-Borja E; Diaz-Gimenez M; Carratala-Calvo A; Magro-Pose P; Perez-Griera J
Clin Biochem; 2021 Nov; 97():82-84. PubMed ID: 34450126
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of anti-SOX1 reactivity in various neurological disorders.
Berger B; Dersch R; Ruthardt E; Rasiah C; Rauer S; Stich O
J Neurol Sci; 2016 Oct; 369():342-346. PubMed ID: 27653921
[TBL] [Abstract][Full Text] [Related]
14. Anti-SOX1 Antibodies in Paraneoplastic Neurological Syndrome.
Sun X; Tan J; Sun H; Liu Y; Guan W; Jia J; Wang Z
J Clin Neurol; 2020 Oct; 16(4):530-546. PubMed ID: 33029958
[TBL] [Abstract][Full Text] [Related]
15. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.
Tschernatsch M; Singh P; Gross O; Gerriets T; Kneifel N; Probst C; Malas S; Kaps M; Blaes F
J Neuroimmunol; 2010 Sep; 226(1-2):177-80. PubMed ID: 20701982
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
18. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
Lipka AF; Verschuuren JJ; Titulaer MJ
Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic neurological syndromes.
Honnorat J; Antoine JC
Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies.
Feldheim J; Deuschl C; Glas M; Kleinschnitz C; Hagenacker T
Neurol Res Pract; 2021 May; 3(1):30. PubMed ID: 34030742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
